Molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961-1997

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 642-650

  Frey, Teryl K ^a   Abernathy, Emily S ^b   Bosnia, Trent J ^b   Starkey, William G ^b   Corbett, Karen M ^b   Best, Jennifer M ^b   Katow, Shigetaka ^b   Weaver, Scott C ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIA; EUROPE; GEOGRAPHIC DISTRIBUTION; INFECTION RISK; NONHUMAN; NORTH AMERICA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; VIRUS GENE;

EID: 0031714434     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515370     Document Type: Article

References (7)

1. Frey TK. Molecular biology of rubella virus. Adv Virus Research 1994;44:69-160.
2. Ukkonen P. Rubella immunity and morbidity: impact of different vaccination programs in Finland, 1979-1992. Scand J Infect Dis 1996;28: 31-5.
3. Centers for Disease Control and Prevention. Rubella and congenital rubella syndrome - United States, 1994-1997. MMWR Morb Mortal Wkly Rep 1997;46:350-4.
4. Miller E, Waight P, Gay N, et al. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1997;7:R26-32.
5. Robertson SE, Cults FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2: vaccination against rubella. Bull World Health Organ 1997;75: 69-80.
6. Lozzi L, Rustici M, Corti M, et al. Structure of rubella El glycoprotein epitopes established by multiple peptide synthesis. Arch Virol 1990;110:271-6.
7. Ilonen J, Seppanen H, Narvanen A, Korkolainen M, Salmi A. Recognition of synthetic peptides with sequences of rubella virus El polypeptide by antibodies and T lymphocytes. Viral Immunol 1992;5:221-8.